Real-World Outcomes of Infants who Initiate Risdiplam Under 2 Months of Age for the Treatment of Spinal Muscular Atrophy (SMA) in the US

Grants and Contracts Details

StatusActive
Effective start/end date11/22/2411/22/26

Funding

  • Health Analytic Research LLC: $2.00